Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.

The central nervous system lesions of multiple sclerosis (MS) can be detected by magnetic resonance imaging (MRI) and the initial perivascular inflammatory component is distinguished by the presence of gadolinium enhancement. To assess the effect of systemic lymphocyte depletion on disease activity,...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Moreau, T, Thorpe, J, Miller, D, Moseley, I, Hale, G, Waldmann, H, Clayton, D, Wing, M, Scolding, N, Compston, A
التنسيق:	Journal article
اللغة:	English
منشور في:	1994

مواد مشابهة

CAMPATH-IH in multiple sclerosis.
حسب: Moreau, T, وآخرون
منشور في: (1996)

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
حسب: Cox, A, وآخرون
منشور في: (2005)

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
حسب: Moreau, T, وآخرون
منشور في: (1996)

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
حسب: Coles, A, وآخرون
منشور في: (1999)

Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
حسب: Coles, A, وآخرون
منشور في: (2003)

Monoclonal antibodies for the depletion of specific subpopulations of lymphocytes.
حسب: Waldmann, H, وآخرون
منشور في: (1987)

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).
حسب: Waldmann, H, وآخرون
منشور في: (1984)

Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype.
حسب: Wing, MG, وآخرون
منشور في: (1995)

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
حسب: Coles, A, وآخرون
منشور في: (1999)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
حسب: Hale, G, وآخرون
منشور في: (1988)

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.
حسب: Coles, A, وآخرون
منشور في: (2006)

Use of Ceprate CD34-positive selection system for depletion of T cells in allogeneic transplantation.
حسب: Hale, G, وآخرون
منشور في: (1997)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
حسب: Isaacs, J, وآخرون
منشور في: (1996)

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
حسب: Chakrabarti, S, وآخرون
منشور في: (2003)

In vitro and in vivo depletion of T cells.
حسب: Arnold, R, وآخرون
منشور في: (1993)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
حسب: Hale, G, وآخرون
منشور في: (1998)

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
حسب: Giovannoni, G, وآخرون
منشور في: (1997)

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.
حسب: Wing, MG, وآخرون
منشور في: (1996)

Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.
حسب: Novitzky, N, وآخرون
منشور في: (2005)

Myeloablative conditioning is well tolerated by older patients receiving T-cell depleted grafts
حسب: Novitzky, N, وآخرون
منشور في: (2005)

Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients
حسب: Marija Radmilo, وآخرون
منشور في: (2023-01-01)

Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.
حسب: Peggs, K, وآخرون
منشور في: (2003)

Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.
حسب: Morrison, J, وآخرون
منشور في: (2005)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
حسب: Hale, G, وآخرون
منشور في: (1994)

T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
حسب: Jacobs, P, وآخرون
منشور في: (1994)

Antibody-mediated cell depletion therapies in multiple sclerosis
حسب: Alice Mariottini, وآخرون
منشور في: (2022-09-01)

Lymphocyte Depletion in Experimental Hemorrhagic Shock in Swine
حسب: Hawksworth Jason S, وآخرون
منشور في: (2012-09-01)

Outcome following T-cell depletion of allogeneic peripheral blood progenitor cells for transplantation
حسب: Novitzky, N, وآخرون
منشور في: (1997)

Preventing the immunogenicity of biological therapies
حسب: Somerfield, J, وآخرون
منشور في: (2011)

MATCHED UNRELATED DONOR BMT FOR CML - COMPARISON OF EXVIVO AND INVIVO T-CELL DEPLETION
حسب: Cullis, J, وآخرون
منشور في: (1992)

The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results
حسب: G. Porciello, وآخرون
منشور في: (2002-03-01)

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
حسب: Novitzky, N, وآخرون
منشور في: (2002)

B-cell depletion therapy for multiple sclerosis
حسب: Yusei Miyazaki, وآخرون
منشور في: (2021-07-01)

T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
حسب: Jacobs, P, وآخرون
منشور في: (1994)

REDUCED INCIDENCE OF GVHD IN RECIPIENTS OF T-CELL DEPLETED MARROW
حسب: Apperley, J, وآخرون
منشور في: (1986)

Hodgkin lymphoma lymphocyte depletion diffuse fibrosis variant
حسب: Alejandro Ruiz Méndez, وآخرون
منشور في: (2008-01-01)

Profound peripheral T-lymphocyte depletion and activation in disseminated tuberculosis
حسب: Denise Silva Rodrigues, وآخرون

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
حسب: Davison, G, وآخرون
منشور في: (2000)

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
حسب: Davison, G, وآخرون
منشور في: (1998)

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation
حسب: Davison, G, وآخرون
منشور في: (1998)